Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBVX.L Regulatory News (BVX)

  • There is currently no data for BVX

BiVictriX Therapeutics makes 'fundamental step forward'

12 Dec 2022 11:38

BiVictriX Therapeutics PLC BiVictriX Therapeutics makes 'fundamental step forward' 12.12.2022 / 12:37 CET/CEST The issuer is solely responsible for the content of this announcement.


Contact Details

Proactive

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

News Source: News Direct

12.12.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.eqs-news.com


Language:English
Company:BiVictriX Therapeutics PLC
United States
ISIN:GB00BNXH3K91
EQS News ID:1510657
 
End of NewsEQS News Service

1510657 12.12.2022 CET/CEST

corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

12
Date   Source Headline
11th Sep 20247:00 amRNSCancellation - BiVictriX Therapeutics plc
10th Sep 202411:04 amRNSHolding(s) in Company
10th Sep 20247:00 amRNSLast Day of Dealings
9th Sep 20247:00 amRNSPositive In Vivo Data from BVX002 Programme
2nd Sep 20245:04 pmRNSHolding(s) in Company
2nd Sep 20248:50 amRNSDirector Dealing
29th Aug 20245:05 pmRNSResult of General Meeting
28th Aug 202410:14 amRNSHolding(s) in Company
28th Aug 202410:12 amRNSHolding(s) in Company
19th Aug 20247:00 amRNSTR-1: Notification of major holdings
13th Aug 20247:00 amRNSGrant of Options
12th Aug 20247:00 amRNSProposed Voluntary Delisting
1st Aug 20247:00 amRNSInterim Results
24th Jul 20245:00 pmRNSResult of Annual General Meeting
26th Jun 20247:00 amRNSPublication of 2023 Annual Report & Notice of AGM
13th Jun 20247:00 amRNSCompelling Safety Profile of BVX001
6th Jun 20247:00 amRNSInnovate UK Grant Award to Accelerate ADC Pipeline
31st May 20248:44 amRNSBiVictriX – Full Year Results 2023
17th Apr 20247:00 amRNSOrphan Drug Designation & FDA INTERACT Meeting
28th Mar 20247:00 amRNSGrant of Options – PDMR/Director Dealings
4th Jan 202412:30 pmRNSHolding(s) in Company
4th Jan 202412:30 pmRNSHolding(s) in Company
4th Jan 20247:00 amRNSBiVictriX Hosts Inaugural Roundtable Discussion
5th Dec 202311:08 amRNSBoard Change
30th Nov 20237:00 amRNSPipeline update on BVX002
22nd Nov 20235:14 pmRNSHolding(s) in Company
15th Nov 20237:00 amRNSPatent Granted in Japan
12th Oct 20237:00 amRNSExtended Survival Rates Reported with BVX001
3rd Oct 20237:00 amRNSAppointment of Adrian Howd as CFO and CBO
19th Sep 20237:00 amRNSInterim Results
31st Aug 20237:00 amRNSTotal Voting Rights
23rd Aug 20237:00 amRNSUS Patent Granted
17th Aug 20237:00 amRNSHolding(s) in Company
16th Aug 20236:00 pmRNSHolding(s) in Company
11th Aug 20234:17 pmRNSHolding(s) in Company
8th Aug 20235:18 pmRNSResult of General Meeting
19th Jul 20236:16 pmRNSResult of Conditional Fundraise
19th Jul 202312:31 pmRNSProposed Fundraise in excess of £2 million
17th Jul 20237:00 amRNSPositive final data in preclinical efficacy study
19th Jun 20237:00 amRNSPositive interim data
6th Jun 20237:00 amRNSBiVictriX nominates clinical candidate for BVX001
4th May 20234:36 pmRNSResult of Annual General Meeting
31st Mar 20237:00 amRNSPublication of Annual Report and Notice of AGM
30th Mar 20237:00 amRNSBiVictriX Full Year Results
1st Mar 20237:01 amRNSAppointment of Alex Hughes as CFO
31st Jan 20237:08 amRNSBiVictriX reports positive BVX001 preclinical data
24th Jan 20234:21 pmRNSHolding(s) in Company
19th Jan 202311:00 amRNSHolding(s) in Company
19th Jan 20237:00 amRNSHolding(s) in Company
16th Jan 20234:32 pmRNSHolding(s) in Company
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.